Edesa Biotech
EDSA
11 hedge funds and large institutions have $97K invested in Edesa Biotech in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
67% more capital invested
Capital invested by funds: $58K → $97K (+$39K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more funds holding
Funds holding: 10 → 11 (+1)
0.01% more ownership
Funds ownership: 0.03% → 0.04% (+0.01%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$18.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$13.1K |
| 3 |
Renaissance Technologies
New York
|
+$11.1K |
| 4 |
AWM
AllSquare Wealth Management
Albany,
New York
|
+$99 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12.7K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$296 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $64K | +$11.1K | +226 | +19% |
|
|
VF
2
Virtu Financial
New York
| $17K | +$18.7K | +380 | New |
|
|
TSS
3
Two Sigma Securities
New York
| $12K | +$13.1K | +265 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $3K | -$12.7K | -257 | -80% |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| $1K | -$296 | -6 | -22% |
|
|
AWM
6
AllSquare Wealth Management
Albany,
New York
| – | +$99 | +2 | New |
|
EDSA Hedge Fund Activity: Q1 2019 in Review
11 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2019, worth a combined $97K — up 67% from $58K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new EDSA positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $18.7K. The largest seller was UBS Group, cutting an estimated $12.7K.
- 11 institutional investors held Edesa Biotech (EDSA) as of Q1 2019, up from 10 in Q4 2018.
- Funds reported $97K of Edesa Biotech stock for Q1 2019, up 67% quarter-over-quarter.
- 3 funds opened new Edesa Biotech positions in Q1 2019 and 2 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q1 2019 was Virtu Financial, an estimated $18.7K added.
- The largest Edesa Biotech seller in Q1 2019 was UBS Group, an estimated $12.7K sold.
Based on aggregated 13F filings for Q1 2019.